Melanoma & Skin Cancer | Specialty

The OncLive Melanoma & Skin Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of skin cancers, including melanoma, basal cell carcinoma, and more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in melanoma and other skin cancers.

Positive Results from First Randomized Study Assessing T-VEC/Ipilimumab Combo in Advanced Melanoma

July 7th 2017

The addition of T-VEC (T-VEC; Imlygic), a herpes simplex virus 1-based oncolytic virus, to CTLA-4 inhibitor ipilimumab (Yervoy) improves the objective response rate in patients with unresected stage IIIb to IV melanoma.

Dr. Schilling on the Importance of Distinguishing Ocular Melanoma

July 6th 2017

Bastian Schilling, MD, University of Wuerzburg, discusses different types of ocular melanoma and the importance of distinguishing this subtype.

Dr. Daud on the Combinations of Immunotherapy for Melanoma

July 6th 2017

Adil Daud, MD, a clinical professor, Department of Medicine at University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses potential combinations of immunotherapy for the treatment of patients with melanoma.

Pembrolizumab Demonstrates Long-Term OS Benefit in Advanced Melanoma

July 6th 2017

Pembrolizumab (Keytruda) provides a long-term survival benefit in both ipilimumab-naïve and ipilimumab-treated patients with advanced melanoma.

Adjuvant Nivolumab Improves RFS Versus Ipilimumab in Melanoma

July 5th 2017

Adjuvant nivolumab (Opdivo) extended recurrence-free survival compared with adjuvant ipilimumab (Yervoy) in patients with advanced melanoma enrolled in the phase III CheckMate-238 trial.

Metastatic Melanoma: Clinical Pearls From the Experts

July 5th 2017

Novel Targeted Therapies for Metastatic Melanoma

July 5th 2017

IDO Inhibitors in Metastatic Melanoma

July 5th 2017

Novel Combinations for Metastatic Melanoma

July 5th 2017

Optimal Treatment of Metastatic Melanoma at Progression

July 5th 2017

Oncolytic Immunotherapy in Metastatic Melanoma

July 5th 2017

New Data for Immunotherapy in Melanoma Brain Metastases

July 5th 2017

Long-Term Results for Immunotherapy in Melanoma

July 5th 2017

How Are You using PD-1 Testing in Melanoma?

July 5th 2017

Options for NRAS-Mutant Melanoma

July 5th 2017

Dual Targeted or Immunotherapy for BRAF-Mutant Melanoma

July 5th 2017

Emerging Adjuvant and Neoadjuvant Options for Melanoma

July 5th 2017

Adjuvant Therapy for Patients with Melanoma

July 5th 2017

Recommendations for Resectability in Melanoma

July 5th 2017

Expert Discusses IDO/PD-1 and Other Emerging Combos in Melanoma

June 30th 2017

Adil Daud, MD, discusses combination regimens and biomarkers being explored to advance immunotherapy in the field of melanoma.